| | 11027-63-7 Basic information More.. |
| Product Name: | Agnuside | | Synonyms: | chasteberry oil;[(1r,2s,6s,7s)-7-hydroxy-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-oxabicyclo[4.3.0]nona-4,8-dien-9-yl]methyl 4-hydroxybenzoate;AGNUSIDE;AGNUSIDE WITH HPLC;AGNUSIDE(P);Agnuside (25 mg);Vitex Oil;Agnoside | | CAS: | 11027-63-7 | | MF: | C22H26O11 | | MW: | 466.44 | | EINECS: | | | Mol File: | 11027-63-7.mol |  |
Use
Agnuside is an known iridoid glycoside found in Vitex herbs or plants. Agnuside have been used in various applications including in the treatment of premenstrual syndrome and regulation of menopause s
ymptoms. This is mainly due to the fact that Agnuside exhibits estrogen-like activities as it interacts with estrogen receptors (ER-alpha) and estrogen receptor-regulated pregesterone receptors. Recen
t studies have also evaluated Agnuside for the probable mechanism of anti-arthritic activity, which suggested the possible development of Agnuside as a therapeutic agent in the treatment of arthritis
by the modulation of the host immune response.
- Agnuside
-
- US $0.00-0.00 / kg
- 2023-10-10
- CAS:11027-63-7
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 50000kg
- Agnuside
-
- US $100.00-25.00 / kgkg
- 2023-09-26
- CAS:11027-63-7
- Min. Order: 1kgkg
- Purity: 0.99
- Supply Ability: 100
- Agnuside
-
- US $0.00 / KG
- 2023-09-26
- CAS:11027-63-7
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
|
|
11027-63-7
Recommend Suppliers |
| Company Name: |
Labnetwork lnc.
Recommend
Complaint |
 |
| Tel: |
+86-27-50766799 |
| FAX: |
|
| Email: |
contact@labnetwork.com |
| Nationality: |
China |
| Products Intro: |
Product Name:[(1R,4aS,5R,7aR)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxybenzoate
CAS:11027-63-7
Purity:95% Package:100g; 1kg Remarks:LN02124022 |
| CB Index: |
58 |
| WebSite: |
www.labnetwork.com |
| Related Information: |
Sales Network
Catalog(19994)
User Evaluation
|
|
|
|
|
|